{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:24:44Z","timestamp":1788459884317,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["U.S.FDA\/CDER"],"award-info":[{"award-number":["U.S.FDA\/CDER"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022416","name":"Center for Drug Evaluation and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.yrtph.2026.106163","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:07:04Z","timestamp":1781050024000},"page":"106163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring the chemical space of pharmaceutical extractables and leachables"],"prefix":"10.1016","volume":"171","author":[{"given":"Lidiya","family":"Stavitskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-3144","authenticated-orcid":false,"given":"Arianna","family":"Bassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Daniel","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Parris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Faramarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Palazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2026.106163_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2023.100275","article-title":"An in silico workflow for assessing the sensitisation potential of extractables and leachables","volume":"27","author":"Chilton","year":"2023","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106163_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13321-016-0174-y","article-title":"ClassyFire: automated chemical classification with a comprehensive, computable taxonomy","volume":"8","author":"Djoumbou Feunang","year":"2016","journal-title":"J. Cheminf."},{"key":"10.1016\/j.yrtph.2026.106163_bib5","series-title":"Read-Across Assessment Framework (RAAF), ECHA-17-R-01-EN","year":"2017"},{"key":"10.1016\/j.yrtph.2026.106163_bib6","series-title":"Chemical Hazards Database (OpenFoodTox)","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106163_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/toxsci\/kfi161","article-title":"Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the national toxicology program in 1997\u20131998","volume":"85","author":"Gold","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106163_bib8","series-title":"ICH Guideline M7 (R2). Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk (No. EMA\/CHMP\/ICH\/83812\/2013), ICH Harmonised Guideline","year":"2023"},{"key":"10.1016\/j.yrtph.2026.106163_bib9","series-title":"ICH Q3C (R9) Guideline on Impurities: Guideline for Residual Solvents - Step 5","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106163_bib10","series-title":"ICH Guideline Q3D (R2) on Elemental Impurities - Step 5","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106163_bib11","series-title":"Guideline for Extractables and Leachables Q3E, Draft Version, Endorsed on 01 August 2025","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106163_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1208\/s12249-015-0368-z","article-title":"Approaches to quality risk management when using single-use systems in the manufacture of biologics","volume":"16","author":"Ishii-Watabe","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.yrtph.2026.106163_bib17","doi-asserted-by":"crossref","DOI":"10.5731\/pdajpst.2025-000007.1","article-title":"Charting the universe of organic extractables and leachables compounds with confirmed identities","author":"Jenke","year":"2025","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106163_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5731\/pdajpst.2015.01046","article-title":"A means of establishing and justifying binary ethanol\/water mixtures as simulating solvents in extractables studies","volume":"69","author":"Jenke","year":"2015","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106163_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5731\/pdajpst.2014.00995","article-title":"A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems","volume":"68","author":"Jenke","year":"2014","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106163_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5731\/pdajpst.2022.012819","article-title":"Characterizing extractables and leachables chemical space to support in silico toxicological hazard assessments","volume":"78","author":"Johnson","year":"2024","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106163_bib22","series-title":"Derek Nexus","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106163_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105494","article-title":"Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls)","volume":"145","author":"Masuda-Herrera","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106163_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5731\/pdajpst.2021.012693","article-title":"Development of duration-based non-mutagenic thresholds of toxicological concern (TTCs) relevant to parenteral extractables and leachables (E& Ls)","volume":"76","author":"Masuda-Herrera","year":"2022","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106163_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yrtph.2018.11.002","article-title":"Molecular fingerprint-derived similarity measures for toxicological read-across: recommendations for optimal use","volume":"101","author":"Mellor","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106163_bib29","series-title":"OECD Series on Testing and Assessment","article-title":"Guidance on grouping of chemicals","year":"2017"},{"key":"10.1016\/j.yrtph.2026.106163_bib28","series-title":"Report on Considerations from Case Studies on Integrated Approaches for Testing and Assessment (IATA) - Series on Testing and Assessment No. 369","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106163_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104802","article-title":"Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: four case studies","volume":"118","author":"Parris","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106163_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5731\/pdajpst.2022.012811","article-title":"Sensitization assessment of extractables and leachables in pharmaceuticals: ELSIE database analysis","volume":"78","author":"Parris","year":"2024","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106163_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/10408444.2022.2065966","article-title":"Framework for sensitization assessment of extractables and leachables in pharmaceuticals","volume":"52","author":"Parris","year":"2022","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106163_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105776","article-title":"Comprehensive extractables and leachables sensitization analysis and practical application of a risk-based approach to sensitization assessment for parenteral drug products","volume":"157","author":"Parris","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106163_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/ci00017a019","article-title":"Structure-activity relationships for skin sensitization potential: development of structural alerts for use in knowledge-based toxicity prediction systems","volume":"34","author":"Payne","year":"1994","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.yrtph.2026.106163_bib36","series-title":"Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products","year":"2006"},{"key":"10.1016\/j.yrtph.2026.106163_bib35","series-title":"Safety Thresholds and Best Demonstrated Practices for Extractables and Leachables in Parenteral Drug Products (Intravenous, Subcutaneous, and Intramuscular)","year":"2021"},{"key":"10.1016\/j.yrtph.2026.106163_bib38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.yrtph.2015.03.001","article-title":"Principles for identification of high potency category chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied","volume":"72","author":"Roberts","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106163_bib39","series-title":"Exploratory Data Analysis","author":"Tukey","year":"1977"},{"key":"10.1016\/j.yrtph.2026.106163_bib40","author":"US EPA"},{"key":"10.1016\/j.yrtph.2026.106163_bib41","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"Seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.yrtph.2026.106163_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.reprotox.2019.07.012","article-title":"ToxRefDB version 2.0: improved utility for predictive and retrospective toxicology analyses","volume":"89","author":"Watford","year":"2019","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106163_bib43","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/ci990307l","article-title":"Prediction of physicochemical parameters by atomic contributions","volume":"39","author":"Wildman","year":"1999","journal-title":"J. Chem. Inf. Comput. Sci."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:41:49Z","timestamp":1785894109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0273230026001364"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106163","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the chemical space of pharmaceutical extractables and leachables","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106163"}}